Detalhe da pesquisa
1.
The legacy of maternal SARS-CoV-2 infection on the immunology of the neonate.
Nat Immunol
; 22(12): 1490-1502, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34616036
2.
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant.
Immunity
; 54(6): 1276-1289.e6, 2021 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33836142
3.
Global patterns of antigen receptor repertoire disruption across adaptive immune compartments in COVID-19.
Proc Natl Acad Sci U S A
; 119(34): e2201541119, 2022 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35943978
4.
The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concern.
PLoS Pathog
; 18(10): e1010882, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36191037
5.
Characterisation of Elevenin-Vc1 from the Venom of Conus victoriae: A Structural Analogue of α-Conotoxins.
Mar Drugs
; 21(2)2023 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36827123
6.
ACE2 expression in adipose tissue is associated with cardio-metabolic risk factors and cell type composition-implications for COVID-19.
Int J Obes (Lond)
; 46(8): 1478-1486, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35589964
7.
Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings.
PLoS Pathog
; 16(9): e1008817, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32970782
8.
Concordance of B- and T-cell responses to SARS-CoV-2 infection, irrespective of symptoms suggestive of COVID-19.
J Med Virol
; 94(11): 5217-5224, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35864567
9.
A structural basis for antibody-mediated neutralization of Nipah virus reveals a site of vulnerability at the fusion glycoprotein apex.
Proc Natl Acad Sci U S A
; 116(50): 25057-25067, 2019 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31767754
10.
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study.
Lancet Oncol
; 22(6): 765-778, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33930323
11.
Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) induces neutralising antibody and polyfunctional T-cell responses in patients with chronic myeloid leukaemia.
Br J Haematol
; 194(6): 999-1006, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34085278
12.
Broad and potent neutralizing antibodies are elicited in vaccinated individuals following Delta/BA.1 breakthrough infection.
mBio
; 14(5): e0120623, 2023 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37747187
13.
Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies.
Elife
; 122023 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36692910
14.
A neutralizing epitope on the SD1 domain of SARS-CoV-2 spike targeted following infection and vaccination.
Cell Rep
; 40(8): 111276, 2022 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35981534
15.
Contrasting Modes of New World Arenavirus Neutralization by Immunization-Elicited Monoclonal Antibodies.
mBio
; 13(2): e0265021, 2022 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35315691
16.
Broad Neutralization of SARS-CoV-2 Variants, Including Omicron, following Breakthrough Infection with Delta in COVID-19-Vaccinated Individuals.
mBio
; 13(2): e0379821, 2022 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35297676
17.
ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants.
Cell Rep
; 39(5): 110757, 2022 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35477023
18.
SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies.
Elife
; 112022 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35587364
19.
Liposome engraftment and antigen combination potentiate the immune response towards conserved epitopes of the malaria vaccine candidate MSP2.
Vaccine
; 39(12): 1746-1757, 2021 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33618946
20.
Guiding the Immune Response to a Conserved Epitope in MSP2, an Intrinsically Disordered Malaria Vaccine Candidate.
Vaccines (Basel)
; 9(8)2021 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34451980